SiriusPoint (SPNT)
NYSE:SPNT
Top Page
SiriusPoint
(NYSE:SPNT)
Select Model
Select Model
Rating:75Outperform
Price Target:
$23.50
▲(1.12% Upside)
Action:ReiteratedDate:03/31/26
SPNT scores well primarily on improved 2025 financial performance and a constructive earnings outlook supported by underwriting discipline and capital actions (preferred redemption and buyback). Valuation is a notable positive due to the very low P/E. The score is tempered by historically volatile profitability/cash flow and reduced confidence from an inconsistency in reported 2025 balance-sheet data, while technical signals are broadly neutral.
Positive Factors
Underwriting improvement and reserving discipline
Sustained combined ratios in the low 90s and a 19-quarter streak of favorable prior-year development indicate durable underwriting improvement and conservative reserving. That track record reduces reserve surprise risk, supports steadier underwriting margins, and underpins across-cycle ROE targets.
Negative Factors
Historic earnings and cash-flow volatility
Material multi-year swings in profitability and cash flow expose the franchise to capital volatility and make multi-year planning harder. The reported inconsistency in 2025 total assets undermines trend analysis and investor confidence, complicating assessments of scale and balance-sheet durability.
Read all positive and negative factors
Positive Factors
Negative Factors
Underwriting improvement and reserving discipline
Sustained combined ratios in the low 90s and a 19-quarter streak of favorable prior-year development indicate durable underwriting improvement and conservative reserving. That track record reduces reserve surprise risk, supports steadier underwriting margins, and underpins across-cycle ROE targets.
Read all positive factors
SiriusPoint (SPNT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.72B
Dividend YieldN/A
Average Volume (3M)647.22K
Price to Earnings (P/E)5.5
Beta (1Y)0.35
Revenue Growth7.87%
EPS Growth-4.68%
CountryUS
Employees1,012
SectorFinancial
Sector Strength70
IndustryInsurance - Reinsurance
Share Statistics
EPS (TTM)0.70
Shares Outstanding116,990,290
10 Day Avg. Volume587,745
30 Day Avg. Volume647,217
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.03
Price to Sales (P/S)0.80
P/FCF Ratio4.96
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit1.98
Enterprise Value/Ebitda3.95
Forecast
1Y Price Target
$25.00Price Target Upside7.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.55
Revenue Forecast (FY)$2.99B
SiriusPoint Business Overview & Revenue Model
Company Description
SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides coverage to various product lines, w...
How the Company Makes Money
SiriusPoint primarily makes money through (1) underwriting income and (2) investment income. Underwriting income is earned when the premiums the company collects for insurance and reinsurance coverage exceed its total costs to service that risk, i...
SiriusPoint Earnings Call Summary
Earnings Call Date:Feb 18, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Positive
The call emphasized strong execution across underwriting, double-digit top-line growth, improved underwriting quality, significant capital actions (MGA sales, preferred redemption, buyback) and disciplined volatility management. Management acknowledged pockets of market weakness (property catastrophe rate declines, selective casualty and reinsurance pressures), one-off acquisition cost noise, and near-term lumpiness in fee income and transaction-related tax effects. Overall, positive operational and capital progress outweigh the identified headwinds.Positive Updates
Top-Line Growth
Gross written premiums (core) grew 16% for the year; Q4 core GWP grew 18% (up $134 million year-over-year) and Insurance & Services GWP grew 26% year-to-date to $2.3 billion.
Negative Updates
Market Headwinds in Certain Lines for 2026
Management acknowledged tougher insurance market conditions in parts of 2026 (notably U.S. and international property catastrophe reinsurance), with U.S. property cat reinsurance rates down roughly 15%–20% at 1/1 renewals and some international accounts failing to meet rate adequacy.
Read all updates
Q4-2025 Updates
Positive
Negative
Top-Line Growth
Gross written premiums (core) grew 16% for the year; Q4 core GWP grew 18% (up $134 million year-over-year) and Insurance & Services GWP grew 26% year-to-date to $2.3 billion.
Read all positive updates
Company Guidance
Management's guidance for 2026 emphasized disciplined underwriting and capital actions: they expect an OUE expense ratio of 6.5–7.0% and model an effective tax rate of ~19%, will redeem $200M of 8% preference shares (reducing leverage to ~23% by end‑February) and intend to repurchase $100M of common stock over 12 months (~4% of shares), which they expect to be accretive to EPS/ROE in 2026 and to book value by 2027. Capital and risk protections include a Q4 BSCR of 247% (pro‑forma 232% after the preferred redemption), a new 2026 aggregate cover attaching at $90M with a $100M annual limit, continued reinvestment at new‑money yields in excess of 4% (portfolio duration ~3.2 years; 81% fixed income, 98% investment grade, avg AA-), and an intentional shift toward insurance (Insurance & Services GWP +26% in 2025 vs Reinsurance +3%) with Accident & Health GWP +23% to ~$1B (~27% of mix); IMG is expected to generate >$30M of fee income and >$35M EBITDA in 2026 (with Assist America and World Nomads each expected to add ~$4–5M EBITDA once integrated). Operational run‑rate targets/signals to watch are a core combined ratio in the low 90s (Q4 core combined ratio 92.9%; full‑year Insurance 91.7%, Reinsurance 91.8%), a 2025 attritional combined ratio of 91.6% (improved 1.5 pts) and a 2025 operating ROE of 16.2% (Q4 17.1%) versus a 12–15% across‑cycle target.SiriusPoint Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
70
Positive
Cash Flow
67
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.21B | 2.61B | 2.70B | 2.17B | 2.22B |
| Gross Profit | 1.69B | 728.40M | 848.40M | 121.30M | 510.40M |
| EBITDA | 622.50M | 314.60M | 393.90M | -376.00M | 85.00M |
| Net Income | 459.60M | 199.90M | 354.80M | -386.80M | 58.10M |
Balance Sheet | |||||
| Total Assets | 121.20M | 12.52B | 12.87B | 11.04B | 10.62B |
| Cash, Cash Equivalents and Short-Term Investments | 902.40M | 3.81B | 3.69B | 4.33B | 2.08B |
| Total Debt | 688.60M | 639.10M | 786.20M | 778.00M | 816.70M |
| Total Liabilities | 7.51B | 10.59B | 10.34B | 8.95B | 8.12B |
| Stockholders Equity | 2.47B | 1.94B | 2.51B | 2.07B | 2.50B |
Cash Flow | |||||
| Free Cash Flow | 514.00M | 74.70M | 581.30M | 292.50M | 1.60M |
| Operating Cash Flow | 514.00M | 74.70M | 581.30M | 293.30M | 1.60M |
| Investing Cash Flow | 423.40M | 343.60M | -332.20M | -1.30B | 208.60M |
| Financing Cash Flow | -512.20M | -625.00M | -61.50M | -23.70M | 24.30M |
SiriusPoint Technical Analysis
Positive
23.24
Price Trends
20.92
Positive
20.96
Positive
19.85
Positive
Market Momentum
0.52
Negative
72.68
Negative
91.74
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SPNT, the sentiment is Positive. The current price of 23.24 is above the 20-day moving average (MA) of 21.21, above the 50-day MA of 20.92, and above the 200-day MA of 19.85, indicating a bullish trend. The MACD of 0.52 indicates Negative momentum. The RSI at 72.68 is Negative, neither overbought nor oversold. The STOCH value of 91.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPNT.
SiriusPoint Risk Analysis
SiriusPoint disclosed 61 risk factors in its most recent earnings report. SiriusPoint reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
SiriusPoint Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $3.08B | 4.91 | 22.09% | ― | 22.79% | -5.17% | |
80 Outperform | $13.35B | 4.70 | 24.24% | 0.57% | -3.96% | -48.08% | |
75 Outperform | $2.72B | 5.55 | 20.87% | ― | 7.87% | -4.68% | |
75 Outperform | $624.62M | 6.59 | 11.10% | ― | 5.83% | -101.38% | |
73 Outperform | $13.85B | 11.38 | 9.48% | 1.76% | 2.10% | 19.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
44 Neutral | $6.13M | -2.82 | -50.32% | ― | ― | 55.30% |
* Financial Sector Average
SPNT
SiriusPoint
23.24
7.46
47.28%
GLRE
Greenlight Capital Re
18.38
5.46
42.26%
RGA
Reinsurance Group
211.30
40.90
24.00%
RNR
Renaissancere Holdings
307.08
76.45
33.15%
OXBR
Oxbridge Re Holdings
0.76
-0.70
-48.22%
HG
Hamilton Insurance Group, Ltd. Class B
31.09
14.57
88.17%
SiriusPoint Corporate Events
Executive/Board Changes
SiriusPoint Refreshes Board with New Independent Director
Positive
Mar 30, 2026
On March 30, 2026, SiriusPoint announced that veteran insurance and financial services executive Sabra R. Purtill had been appointed to its Board of Directors, effective March 25, 2026, as a Class I director through the May 20, 2026 annual general...
Executive/Board Changes
SiriusPoint Announces Departure of International Insurance CEO
Neutral
Mar 23, 2026
On March 16, 2026, SiriusPoint Ltd. disclosed that Rob Gibbs, President and Chief Executive Officer of SiriusPoint International Insurance Corporation, would depart the company, and on March 17, 2026, the two parties agreed a settlement governing ...
Business Operations and StrategyExecutive/Board Changes
SiriusPoint Unveils Global Restructuring and London Market Focus
Positive
Mar 16, 2026
On March 16, 2026, SiriusPoint Ltd. announced a restructuring that will see the specialty insurer and reinsurer operate through four core business areas: Global PC Programs, Global Reinsurance, Global Accident Health, and a new London Market Spec...
Business Operations and StrategyStock BuybackFinancial Disclosures
SiriusPoint Posts Strong Q4 Results, Launches Buyback Plan
Positive
Feb 18, 2026
On February 18, 2026, SiriusPoint reported fourth-quarter 2025 net income of $240 million, or $1.97 per diluted share, with operating EPS of $0.70, an annualized ROE of 44.9% and operating ROE of 17.1%. The quarter saw 18% growth in gross and net ...
Business Operations and StrategyM&A Transactions
SiriusPoint Expands Travel Insurance Platform With World Nomads Acquisition
Positive
Feb 12, 2026
On February 12, 2026, SiriusPoint’s subsidiary Sirius International UK Holdings II Ltd. agreed to acquire the World Nomads travel insurance business from Australian health insurer nib Group via a share and asset sale. World Nomads, with abou...
Business Operations and StrategyM&A Transactions
SiriusPoint Completes Strategic Divestment of Arcadian Stake
Positive
Jan 30, 2026
On January 30, 2026, a SiriusPoint Ltd. subsidiary completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited, a Bermuda exempted company, to Comet Bidco Limited, an acquisition vehicle affiliated with Lee Equi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.